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A human liver cDNA clone which encodes the UDP-glucose pyrophosphorylase was isolated by complementation of a bacterial galU mutant. The 
deduced amino acid sequence of the human enzyme comprised 508 amino acids with a calculated molecular mass of 56,950. The human enzyme 
significantly resembles those of potato tuber and slime mold with a homology of 46.6% and 43.2%, respectively, in amino acid sequence. No 
homology was found between the eukaryotic and the prokaryotic enzymes. Northern blotting analysis revealed that the gene was expressed at the 
highest level in skeletal muscle, followed by liver, heart and kidney. 
E. coli gale Glycogen; UDP-glucose pyrophosphorylase cDNA 
1. INTRODUCTION 
Much of the carbohydrates that enter the hepatocyte 
are stored in the form of glycogen which functions as 
a reserve of glucose which can be rapidly utilized during 
fasting to maintain normoglycemia. The precursor for 
glycogen synthesis is a uridine diphosphate glucose 
(UDPG) converted from glucose- 1 -phosphate by a spe- 
cific enzyme called UDPG pyrophosphorylase 
(UTPglucose-l-phosphate uridylyltransferase) (EC 
2.7.7.9). In a second reaction catalyzed by glycogen 
synthase (EC 2.4.1.21), the glucose from UDPG is at- 
tached to a glycogen primer through a (al+ bond, 
lengthening the glucose chain. 
In addition to serving as a direct precursor for glyco- 
gen synthesis, UDPG is also required for normal galac- 
tose metabolism in organisms which utilize the Leloir 
pathway [l]. In Gram (-) bacteria, the UDPG pyro- 
phosphorylase is encoded by the galU gene. The Escher- 
ichia coli galU mutants mimic the mutants defective in 
gal operon (galETa in several ways such as increased 
sensitivity to galactose, inability to ferment galactose 
and synthesize polysaccharides [2,3]. Since the enzy- 
matic properties of the human UDPG pyrophosphory- 
lase is very similar to that of the bacterial enzyme [48], 
it is likely that the human cDNA clone encoding the 
UDPG pyrophosphorylase may be obtained by comple- 
mentation of the galU defects in bacteria. We here re- 
port the successful isolation of a human UDPG pyro- 
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phosphorylase cDNA clone by such a strategy. The 
nucleotide sequence and expression pattern of this gene 
in various human organs were also determined. 
2. MATERIALS AND METHODS 
2.1. cDNA library screening 
A human liver cDNA library, constructed in the lambda ZAP vector 
unidirectionally in EcoRI-XhoI sites, was purchased from Stratagene 
(Cat. no. 937200, LaJolla, CA, USA). A phagemid library was gener- 
ated from the library by in vivo excision as recommended by the 
supplier. E. coli galU mutant strain FF4001 (MC4100, gaZU95) was 
a generous gift of Dr. Svein Valla, University of Trondheim, Norway 
[9]. E. coli strain HU735 (C600, F’ Zac::Tti), which was used as a 
donor of F factor, was obtained from Dr. Jonathan Ou in our depart- 
ment. MacConkey-galactose agar was prepared with MacConkey 
agar base (Difco Inc., Detroit, MI, USA) supplemented with 0.2% 
galactose. E. co/i strain JM109 was routinely used as the recombinant 
DNA host. 
2.2. Recombinant DNA techniques and DNA sequencing 
All restriction enzymes and DNA modifying enzymes were obtained 
either from Promega (Madison, WI, USA) or Boehringer Mannheim 
(Germany) and used under the conditions recommended by the suppli- 
ers. All recombinant DNA experiments were carried out essentially as 
described [lo]. The DNA fragments were subcloned into Ml3mplB 
and mp19 and sequenced with Sequenase (US Biochemical, Cleveland, 
OH, USA) and [?S]dATP (Amersham, Arlington Heights, IL, USA) 
as described by the manufacturer, with either the universal M13 
primer or synthetic oligonucleotides [l 11. The sequence was confirmed 
in both strands, and the question of compressions was resolved by 
sequencing with dITP. Nucleotide sequence was analyzed with the 
DNASTAR program (DNASTAR Inc., Madison, WI, USA) using a 
Macintosh LC computer. 
2.3. Assay of UDPG pyrophosphorylase activity 
Bacteria were grown in Luria broth supplemented with 10 PM 
IPTG (isopropyl-/I-o-thiogalactopyranoside) until OD, = 1 .O, then 
were harvested by centrifugation. The pellets were resuspended into 
a buffer containing 50 mM Tris-HCl, pH 7.8,lO mM MgCl,, and 1.0 
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mM 2-mercaptoethanol, and cells were disrupted by sonication. The 
lysate was clarified by centrifugation at 20,000 x g and protein concen- 
tration of the supernatant was determined by the method of Bradford 
[12] using the Bio-Rad Protein Assay. The assay procedure for UDPG 
pyrophosphorylase was modified from the procedure of Fujimura et 
al. [13] which was designed to determine the concentration of UDPG. 
The reaction mixture contains 50 mM Tris-HCl, pH 7.8, 10 mM 
MgCl,, 1 mM 2-mercaptoethanol, 1.0 mM UTP, 1.0 mM glucose-l- 
phosphate, 1 mM NAD, 0.05 units UDPG dehydrogenase (Boehrin- 
ger Mannheim, Germany) and cell extract, in a final volume of 0.5 ml. 
Reactions were performed at 37°C for 30 min and the reduction of 
NAD was measured spectrophotometrically at 340 nm. The activity 
was defined as the amount of UDPG synthesized per min per mg 
protein. 
2.4. Northern blotting analysis 
A Multiple Tissue Northern (MTN) blot was obtained from Clon- 
tech (Palo Alto, CA, USA). This blot was made with poly(A)+ RNA 
from eight different tissues of human, electrophoresed on denaturing 
agarose gel and blotted onto charged modified nylon membrane. The 
hybridization procedure and preparation of “P-labeled DNA probes 
were performed essentially as described [lo]. 
3. RESULTS AND DISCUSSION 
3.1. Cloning strategy 
Bacterial mutants defective in the UDPG pyro- 
phosphorylase (GalU) are suitable for complementa- 
tion cloning for two reasons. First, the galU defect pre- 
vents the mutants from growing on galactose-contain- 
ing agar. This provides a convenient means to select the 
Gal’ bacteria from the Gal- bacteria. Secondly, the 
ability of fermenting galactose, which requires a func- 
tional UDPG pyrophosphorylase, can be easily deter- 
mined by the color of colonies using MacConkey-galac- 
tose agar. Upon transformation with a human liver 
cDNA library, any transformant of Gal’ phenotype, as 
determined by its ability to grow into red colonies on 
McConkey-galactose plates, is presumed to contain a 
human UDPG pyrophosphorylase cDNA clone. 
3.2. Cloning of human cDNA capable of complementing 
the E. coli galU mutation 
A human liver cDNA library constructed in the 
lambda ZAP vector was used for screening for its capa- 
bility of conversion into the phagemid form by in vivo 
excision. The phagemids can then be transfected into a 
E. coli galU mutant carrying the F plasmid with high 
efficiency. To construct a suitable phagemid recipient 
strain, F factor was mobilized from E. coli HU73.5 to 
galU mutant strain FF4001 via conjugation, resulting 
in E. coli HP069. About 5 x lo4 recombinant phagemid 
clones were transfected E. coli galU mutant strain 
HP069. The transfected bacteria were washed once with 
0.85% NaCl and plated onto MacConkey-galactose 
agar supplemented with 50 ,&ml of ampicillin. About 
60 colonies were isolated, which were capable of fer- 
menting galactose and manifested as red colonies on the 
MacConkey-galactose plates. To eliminate spontaneous 
revertants or contaminating bacteria, plasmid DNA 
was prepared from 12 of these Gal’ clones and retrans- 
154 
formed into E. coli HP069. All transformants of the 12 
plasmids examined exhibited galactose insensitive phe- 
notype and were positive in galactose fermentation. Tr- 
ansformants with the pBluescript vector alone remained 
Gal-. These plasmids were further digested with restric- 
tion endonuclease EcoRI, and analyzed on a 2% aga- 
rose gel. All 12 plasmids yielded a DNA fragment with 
varying sizes ranging from 850 to 1,150 bp and a com- 
mon 200 bp EcoRI restricted fragment. Hybridization 
of these plasmids with the 1,150 bp DNA fragment as 
a probe indicated all these samples share a common 
nucleotide sequence (data not shown). It is apparent 
that all these cDNA clones are derived from an identical 
gene, presumably the gene encoding the human liver 
UDPG pyrophosphorylase. The clone with the longest 
insert, designated pHC308, was selected and used for 
further study. 
3.3. Analysis of the biological activity of the pHC308 
clone in E. coli 
In addition to the complementation study, more solid 
evidence supporting that pHC308 encodes a UDPG py- 
rophosphorylase activity came from the analysis of the 
enzymatic activity in the transformant. As demon- 
strated in Table I, the UDPG pyrophosphorylase activ- 
ity in E. coli HPO69[pHC308] is about 20 times higher 
than the activity in HPO69[pBluescript]. Therefore, it 
can be concluded that pHC308 contains a human liver 
cDNA clone encoding a UDPG pyrophosphorylase. 
3.4. Nucleotide sequence analysis of human UDPGpyro- 
phosphorylase cDNA clone 
The human UDPG pyrophosphorylase cDNA con- 
tained in the pHC308 comprised 1,984 nucleotides (Fig. 
1). One major open reading frame was observed which 
is capable of coding a protein of 508 amino acid in 
length. The predicted molecular mass is 56,950 Da, 
which matches perfectly with the size of the purified 
bovine enzyme (Boehringer Mannheim) analyzed on 
SDS-polyacrylamide gel electrophoresis. The result is 
also in agreement with the previous report which 
showed that the molecular weight of the mammalian 
enzyme is approximately 400 kDa with eight identical 
subunits [14]. 
3.5. Sequence comparison with UDPG pyrophosphory- 
lase from other sources 
The UDPG pyrophosphorylase gene has been re- 
Table I 
UDPG pyrophosphorylase activity of the cDNA clone in E. coli 
Escherichia coli strains UDPG pyrophosphorylase activity 
(nmol/min/mg protein) 
HPO69[pBluescript] 12.5 
HPO69[pHC308] 251.4 
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AATAGTTCCTTAAGTAGCTAACCATCGGAGGAGAAAGAACACATCGGTTGTTGCTTGA 
AAGGAAGGGAGACCTTCCTTATAACGCAACTCCGAGAAATTG~AATTATAAACCAGATTATTTTAATATAACCCGAAA 
AYG T:G A:A T;T GYG C:A G:C C:T A:t A:A GtT A:G T:T C!A G:T GET G:T T;T C:G T:C 
QEVILQELELSVKKELEK 
CAA GAA GTC ATT CTC CAA GAA CTA GAA TTA TCT GTG AAG AAA GAA TTA GAA AAA A:A C:T 
E T K 
A:A A:A GtA A:C T:A C!T GAG T:T G:G C!T ACT A!A AAA G:T C:T G:T G:A T!T C!G AkG 
C:A T:T C:T A:A T;T TkG C:A G:A A:G G:A C!T T:T GYA G:C T:G G:T A!A A:C C:G A;A 
PPEDSIOPYEKIKARGLPDN 
CCT CCA GAA GAT TCG ATT CAA CCC TAT GAA AAG ATA AAG GCC AGA GGC CTG CCT GAT AAT 
ISSVLNKLVVVKLNGGLGTS 
ATA TCT TCT GTG TTG AAC AAA CTG GTG GTG GTG AAA CTC AAT GGT GGT TTG GGA ACC AGT 
A?G G:C T:C AtA G:C C!T A!A A:T CkG A:T GET G:A A:A AtT G:G A!T A:C T:T T:G G!T 
CbA A:T G!G C:G CEtA A:T G:A C!T TkG A!tC A:A A:C Tj;C AFT A:A G:T Gk C!T CkT G;T 
K 
T:A A?G AfC T:T T:T A!k A:G G!T G:A G:C A:A A:A AAA A:A CtiT C:G A:G T:C A!T C!T 
CRVKIYTFNQSRYPRINKES 
TGC CGT GTG AAA ATC TAC ACC TTC AAT CAA AGC AGG TAT CCG AGG ATT AAT AAG GAA TCT 
T:A C!G CR G:A GtA A%G G:T G;G T:T T;C TEA G:G G:A A:T A:A G:A GtT T!G T:C CC'C 
G G D Y N S 
C!A GGA C!T GGA GAT A:C T:T GtT A:T T:C TAC AAC TCG G;C TIjG C:C G:C A:C T;T C:A 
EEGKEYIFVSNIDNLGATVD 
GAA GAA GGC AAA GAG TAT ATT TTT GTT TCT AAC ATA GAT AAC CTG GGT GCC ACA GTG GAT 
261 L Y I L N H L I N P P N G K R C E F V M 
;;; CTT TAT ATT CTT AAT CAT CTA ATC AA& WA CCC AAT GGG AAA CGC TGT GAA TTT GTC ATG 
978 G:A G!C A:A A!T A!A A:A C:A GtA G:T G!A A!G G!T G:A A;A Ct;C A:T C:A T:T G:A G:C 
301K L R L V E I A Q V P K A H V D E F K S 
1;;': AAA CTG AGA CTG GTG GAG ATT GCT CAA GTG CCA AAA GCA CAT GTT GAT GAA TTC AAG TCT 
1;;; G:G T:A A!A T:T A!A A:A TF;T A!k A:A Ak A!C C:A T!G A:C T;T CLiT G:A GtA G:T A!A 
1158 A:A CkG C:G G:G C:G A!T Gk A:T G!C A!G G:A A:C A:T G:G A!T C!A A!G A:T T:G GZiT 
361 G G L N V I Q L E T A V G A A iK S F E 
';A': GGA GGC CTG AAT GTT ATT CAG TTA GAA ACT GCA GTT GGA GCT GCA ATT AAA AGT TTC GAG 
NSLGINVPRSRFLPVKTTSD 
1;;': AAT T&T TTA GGT ATT AAT GTT CCA AGG AGT CGT TTT CTG CCT GTG AAG ACC ACG TCA GAT 
';3': CkC T:G C\T GjG A;G T:A Ak C:C TIT A:C Cff A!T GtA G:A T;T TkG A;C A:G A:T G:A 
$7 A!G C:G G:G TTT C:T A:A G:A C!C T:G G:T A!A T\A G:A A:T Tk T!T A:C A!G G;T C:A 
1;;: G:T T:C CkA A!G AtG T!T G:A A;T A:A C:T G:C A:G CkG GkA TkG G:T C!C C:C A:T GYT 
126l': T;T G:A G:T GYG A:A T!T G!A A:A A!T GYT T:A TkA A:G G:A A:A G:T A:C A:T A:T G:A 
1;;: A!T CtT G:T G:C A!A A:T G:C A:C C!C C!T G:A GtA G;G T:A G:G AtC A!G A:C G:A T:T 
1638 G:A A!T C:T C:A A:C T:G G:T C!h T;A GATAAGCGCTGCCGGATACACTTTATACTAATTATGGGTTAAA 
1708 CAGTTTCTTGTAATAAAATGTCCTCTAAGATTCTCAAATGAGCAAGTACTTTTACTGTGCAGTGTTGATTTTTTAGAGT 
1795 TTTCTGCAATGTGCTTTTAGCCTAAA~GAAGATAGATGGAGCAGTACTGTC~TTTTTTGATGAAGAG~&TAGAGATGA 
1866 GTTCATCTAAAAGTGCAATATTATTTATCGTAGAACTGGGCCAGCTCGGCAATCTTTTAACAGAAGCTGGAGTGATGG 
1945 TCTTTGATTGCCTTTGATTTTAA~ATA~GTGATACAAC 
Fig. 1. Nucieotide sequence and deduced amino acid sequence of human UDPG pyrophospho~iase. The nucleotide sequence is numbered in the 
5’40-3 direction beginning at the first position of the EcoRI linker. The amino acid sequence is numbered from the first methionine at the putative 
translation initiation site. These data have been submitted to the GenBank data base and have been assigned accession number L14430. 
ported from three evolutional-diversed organisms, Ace- those of the same enzyme from these sources, significant 
tobacter xylinum [15], potato [16], and the slime mold, homology of the human enzyme with the other two 
Dictyostelium discoideum [17]. The two eucaryotic pro- eucaryotic enzyme was noted (Fig. 2). A 43.2% identity 
teins show significant (42%) sequence homology with (220 out of 508 matchable residues) was noted between 
each other. No homology was found between the bacte- the enzyme of human and of the slime mold and 46.6% 
rial enzyme and either of the two eucaryotic enzymes. (237 out of 508 residues) between the human enzyme 
By comparison of the human enzyme sequence with and the enzyme from potato tuber. All these eucaryotic 
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:M:MTDTATSKATVERPKLPSTGSLHSLFKDVDLFSENDEELV 
PT I 
MSRFVQDL~KANSQ[GA~QFQ~V I L 
MATAT 
:::~~~KS~T~]D’~U~LQ[111”“‘“0”8 
NPDYNVDVPLV MNSV THN TNK IEKVKTHKVSl 
125 IEALNAKFGCSVPLLLMNSFNTHDDTlKlVEKYANSNlDl 
186Y TFNQSRYPRlNKESLRPVAKDVS!-!&jGESTEAWYPpGHGD 
,65H~Q@MV~T~N~p~pNTInHpKE m/ IPPKTF~PSM 
PRLYTEDFAPLPCKGNDGKDG 
347ji9 D M E I I V N 
351 KLDIL DW[l V N 
TLIDC]GlNVIQLETAVCAAlKSFENSLGlNV 
321HLK(M E I ImN 
LENHKAMV QLETPACml 0 n ~~N[K&&@-j 
EVaVKVL QLETAAGAAIKFFDRAIGANV 
Fig. 2. Amino acid sequence comparison between human, potato tuber and slime mold UDPG pyrophosphorylases. The positions of the amino 
acid residues are indicated to the left. Residues identical with those of the human enzyme are boxed. The abbreviations are as follows: H, human; 
SM, slime mold; PT, potato tuber. 
genes resemble one another over the entire sequence 
except about 100 amino acids at the N terminus where 
no homology was observed. In fact, much of these N- 
terminal sequences may not be critical for the catalytic 
activity of the human enzyme. One of the cDNA clones 
which encodes an enzyme truncated upta 43 amino acid 
residues at the N terminus remains able to complement 
the g&J defect of E, coli mutant HP069. A site-specific 
mutagenesis has demonstrated that three lysyl residues 
are important for the normal function of the potato 
tuber UDPG pyrophospho~lase [181. Two of the sites, 
Lys-367 and Lys-265 in the potato tuber enzyme, are 
also Gonserved in the human enzyme. Like the other two 
eucaryotic enzymes, no homology was observed be- 
tween the human and bacterial UDPG pyraphosphory- 
lase. 
3.6. Northern analysis of human UDPG pyrophosphory- 
law gene 
Except for the liver and ovary [ 191 in which relatively 
abundant UDPG pyrophosphorylase activity were 
noted, the distribution of the enzyme activity in differ- 
ent organs and tissue types is not clear. To investigate 
the expression level of this gene in various organs, the 
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Fig. 3. Northern blotting analysis of the human UDPG pyro- 
phosphorylase gene expression. Lanes 1, heart; 2, brain; 3, placenta; 
4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, pancreas. The probes 
used in this experiment are pHC308, the human UDPG pyro- 
phosphorylase cDNA (A) and/J-actin gene (B). The molecular weight 
markers are marked by arrows on the left. 
cDNA insert was excised from pHC308, 32P-labeled, 
and used as a probe to hybridize a Northern blot which 
contains poly(A) RNA from eight different human 
organ sources. As demonstrated in Fig. 3, all testing 
organs exhibit a single transcript of 2.2 kb in length 
comparable to the size of the cDNA clone. The result 
suggests that the pHC308 contains a nearly full length 
cDNA encoding the human UDPG pyrophosphorylase. 
This gene is found to express in all organs tested, with 
the highest level in skeletal muscle, followed by liver, 
heart, and kidney. By using a /I-actin cDNA as a probe, 
the amount of poly(A) RNA of the skeletal muscle on 
the Northern blot was found to be slightly higher than 
in the other samples. Nevertheless, as measured by a 
densitometer, the amount of UDPG pyrophosphorylase 
gene transcript in skeletal muscle is still twice as much 
as that in liver. Our result is in agreement with the fact 
that in the human body, skeletal muscle and liver are the 
major organs that store glycogen. Further experiments 
are needed to confirm if the enzyme activities in these 
organs are indeed correlated with the expression level. 
3.6. Conclusion and prospects 
The UDPG pyrophosphorylase is an important meta- 
bolic enzyme which has been purified from plant [20,21] 
and animal [7,8] tissues, E. coli [4,5] and slime mold, D. 
discoideum [22]. In some species of Enterobacteriaceae, 
mutant strains with UDPG pyrophosphorylase defi- 
ciency are altered in the carbohydrate part of the 
lipopolysaccharides [2,3]. The alteration also affects the 
synthesis of bacterial flagella [23], the utilization of ga- 
lactose [2], and osmoregulation [24]. The enzyme also 
participates in sucrose and cellulose formation in plants 
[25,26] and in bacteria [27] and the developmental regu- 
lation in D. discoideum [28]. In mammalian cells, the 
deficit of UDPG may result in decreased synthesis of 
membrane glycoproteins necessary for normal differen- 
tiation and maintenance of the integrity of cells. Fur- 
thermore, the defects of the UDPG pyrophosphorylase 
may cause abnormal galactose utilization and glycogen 
synthesis. Recent finding of the association between an 
XbaI restriction fragment length polymorphism of the 
glycogen synthase gene and non-insulin-dependent dia- 
betes mellitus (NIDDM) [29] suggest that UDPG pyro- 
phosphorylase, the rate-limiting enzyme of the glycogen 
biosynthesis pathway [30], may link to the disease as 
well. The human liver cDNA clone and its nucleotide 
sequence reported in this paper will provide useful in- 
formation for further studies of the human UDPG py- 
rophosphorylase at the molecular biology level and its 
implications in NIDDM and related carbohydrate met- 
abolic problems. 
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